Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03022383 · ClinicalTrials.gov registry record
TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 10
- Enrollment target
NCT03022383: Completed study, sponsored by Topcon Medical Systems.
NCT03022383 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03022383 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
To determine optimal cut-off value for the TopQ cut-off on the DRI OCT Triton plus
Interventions
- DEVICE DRI OCT Triton plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-04 |
What the finished NCT03022383 record still lists
NCT03022383 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DRI OCT Triton plus is the first listed.
NCT03022383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03022383 about?
NCT03022383 is a clinical study titled "TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus". To determine optimal cut-off value for the TopQ cut-off on the DRI OCT Triton plus
What is the current status of trial NCT03022383?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT03022383?
The interventions under investigation include: DRI OCT Triton plus (DEVICE).
Who is sponsoring clinical trial NCT03022383?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia